Literature DB >> 30929259

miR-378a Modulates Macrophage Phagocytosis and Differentiation through Targeting CD47-SIRPα Axis in Atherosclerosis.

Wenna Chen1,2, Ximing Li1, Junyan Wang3, Nan Song1, Aisong Zhu4, Lianqun Jia1.   

Abstract

BACKGROUND: Signal regulatory protein alpha (SIRPa) is an essential signalling molecule that modulates inflammatory responses in macrophages. However, the regulation of SIRPs and its dynamic changes in macrophages under inflammatory stimulation in atherosclerosis remain uncertain.
OBJECTIVE: The study aimed to identify the miRNAs that regulate SIRPa transcription and their roles in modulating phagocytosis, differentiation and cholesterol efflux in macrophages.
METHODS: ApoE knockout mice were fed with a high-fat diet for 12 weeks. Intimal lesion areas and lipid accumulation were assessed by haematoxylin and eosin (HE) and oil red O staining. The expression of mRNAs/miRNAs was assessed by RNA-seq (RNA sequencing) and RT-qPCR (real-time quantitative polymerase chain reaction). The identification of miR-378a associated with SIRPa regulation in macrophages induced by ox-LDL was confirmed by RT-qPCR and Western blot. The phagocytosis and differentiation of macrophages were detected to figure out the role of miR-378a and SIRPa.
RESULTS: SIRPa was proved to be a target of miR-378a. Reduced miR-378a can promote the expression of SIRPa. RNA-seq data showed that the levels of mRNA associated with macrophage phenotypes and SIRPa-CD47 axis were increasing significantly with a decreasing phagocytic phenotype in ApoE-/- mice vs wild-type (WT) mice (P < 0.01). The level of miR-378a was reduced in the aorta of ApoE-/- mice vs WT mice. The experiment in vitro showed that overexpression of miR-378a in macrophages decreased the level of Sirpa mRNA obviously vs control (P < 0.01). The phagocytic activity of miR-378a-transfected macrophages was promoted vs control (P < 0.05). miR-378a significantly depleted Sirpa levels in oxidized low-density lipoprotein (ox-LDL)-stimulated macrophages (P < 0.05), and depletion of miR-378a reversed Sirpa reduction obviously (P < 0.05). miR-378a promoted the secretion of TNF-a and IL-6 indirectly.
CONCLUSION: It has been demonstrated that miR-378a regulates SIRPa-mediated phagocytosis and polarization of macrophages by a direct or indirect way. This research may provide a new path to promote reverse cholesterol transport of macrophages and hinder the progress of atherosclerosis.
© 2019 The Foundation for the Scandinavian Journal of Immunology.

Entities:  

Keywords:  SIRPa; atherosclerosis; inflammation; micro-RNA

Mesh:

Substances:

Year:  2019        PMID: 30929259     DOI: 10.1111/sji.12766

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  18 in total

Review 1.  MicroRNAs as Regulators of Phagocytosis.

Authors:  Wojciech Gierlikowski; Barbara Gierlikowska
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

Review 2.  Emerging Concepts of Vascular Cell Clonal Expansion in Atherosclerosis.

Authors:  Ashish Misra; Rajan Rehan; Alexander Lin; Sanjay Patel; Edward A Fisher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-02-03       Impact factor: 10.514

3.  Notoginsenoside R1 upregulates miR-221-3p expression to alleviate ox-LDL-induced apoptosis, inflammation, and oxidative stress by inhibiting the TLR4/NF-κB pathway in HUVECs.

Authors:  Lingbo Zhu; Xinyan Gong; Jianping Gong; Yungang Xuan; Ting Fu; Shimao Ni; Lei Xu; Ningning Ji
Journal:  Braz J Med Biol Res       Date:  2020-05-08       Impact factor: 2.590

Review 4.  MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis.

Authors:  Emma L Solly; Catherine G Dimasi; Christina A Bursill; Peter J Psaltis; Joanne T M Tan
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

Review 5.  microRNAs involved in psoriasis and cardiovascular diseases.

Authors:  Sara Sileno; Sara Beji; Marco D'Agostino; Alessandra Carassiti; Guido Melillo; Alessandra Magenta
Journal:  Vasc Biol       Date:  2021-06-03

6.  Development of a Novel Immune Infiltration-Related ceRNA Network and Prognostic Model for Sarcoma.

Authors:  Deyao Shi; Shidai Mu; Feifei Pu; Binlong Zhong; Binwu Hu; Jianxiang Liu; Tongchuan He; Zhicai Zhang; Zengwu Shao
Journal:  Front Cell Dev Biol       Date:  2021-07-01

Review 7.  Recent Advancements in CD47 Signal Transduction Pathways Involved in Vascular Diseases.

Authors:  Manman Dou; Ying Chen; Jian Hu; Di Ma; Yingqi Xing
Journal:  Biomed Res Int       Date:  2020-07-15       Impact factor: 3.411

8.  Identification of Altered miRNAs in Cerumen of Dogs Affected by Otitis Externa.

Authors:  Cristina Lecchi; Valentina Zamarian; Giorgia Borriello; Giorgio Galiero; Guido Grilli; Mario Caniatti; Elisa Silvia D'Urso; Paola Roccabianca; Roberta Perego; Michela Minero; Sara Legnani; Raffaele Calogero; Maddalena Arigoni; Fabrizio Ceciliani
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561

Review 9.  The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation.

Authors:  Anastasia Poznyak; Andrey V Grechko; Paolo Poggio; Veronika A Myasoedova; Valentina Alfieri; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2020-03-06       Impact factor: 5.923

10.  Pravastatin-induced changes in expression of long non-coding and coding RNAs in endothelial cells.

Authors:  Shweta Singh; Hien C Nguyen; Mehroz Ehsan; David C R Michels; Priyanka Singh; Mohammad Qadura; Krishna K Singh
Journal:  Physiol Rep       Date:  2021-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.